Phyllis A. Gimotty

32.6k total citations · 7 hit papers
240 papers, 20.1k citations indexed

About

Phyllis A. Gimotty is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Phyllis A. Gimotty has authored 240 papers receiving a total of 20.1k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Oncology, 72 papers in Molecular Biology and 47 papers in Immunology. Recurrent topics in Phyllis A. Gimotty's work include Cutaneous Melanoma Detection and Management (50 papers), Immunotherapy and Immune Responses (31 papers) and Melanoma and MAPK Pathways (19 papers). Phyllis A. Gimotty is often cited by papers focused on Cutaneous Melanoma Detection and Management (50 papers), Immunotherapy and Immune Responses (31 papers) and Melanoma and MAPK Pathways (19 papers). Phyllis A. Gimotty collaborates with scholars based in United States, Italy and Canada. Phyllis A. Gimotty's co-authors include George Coukos, Lin Zhang, Dionyssios Katsaros, Stephen C. Rubin, José R. Conejo-García, M Massobrio, G. Regnani, Heidi J. Gray, Michael Liebman and Antonis Makrigiannakis and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Phyllis A. Gimotty

229 papers receiving 19.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Final Version of 2009 AJCC Melanoma Staging and Classification

2009 3.3k citations Charles M. Balch, Jeffrey E. Gershenwald et al. Journal of Clinical Oncology profile →
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer

2003 2.6k citations Lin Zhang, Dionyssios Katsaros et al. profile →
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

2011 1.1k citations Andrea Barchetti, Phyllis A. Gimotty et al. profile →
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth

2010 872 citations Alexander Roesch, Devraj Basu et al. profile →
microRNAs exhibit high frequency genomic alterations in human cancer

2006 829 citations Lin Zhang, Jia Huang et al. profile →
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

2008 800 citations Andres J. Klein–Szanto, Phyllis A. Gimotty et al. profile →
Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells

2013 487 citations Alexander Roesch, Phyllis A. Gimotty et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phyllis A. Gimotty United States	60	10.5k	8.4k	5.6k	3.9k	2.0k	240	20.1k
Donna Neuberg United States	113	14.0k 1.3×	14.4k 1.7×	9.5k 1.7×	4.4k 1.1×	2.0k 1.0×	719	46.3k
John A. Glaspy United States	75	10.9k 1.0×	5.1k 0.6×	5.3k 0.9×	1.8k 0.5×	1.1k 0.5×	338	21.4k
Thomas E. Witzig United States	101	13.5k 1.3×	11.2k 1.3×	6.0k 1.1×	1.8k 0.5×	2.2k 1.1×	778	34.1k
Peter H. Watson Canada	72	7.2k 0.7×	9.1k 1.1×	2.9k 0.5×	5.0k 1.3×	1.3k 0.6×	259	19.5k
William E. Grizzle United States	82	6.3k 0.6×	14.1k 1.7×	3.9k 0.7×	6.4k 1.6×	1.6k 0.8×	499	26.2k
Patrice Viens France	61	10.5k 1.0×	6.0k 0.7×	2.2k 0.4×	5.6k 1.4×	771 0.4×	353	17.5k
Alexander M.M. Eggermont Netherlands	72	18.5k 1.8×	9.4k 1.1×	6.7k 1.2×	2.7k 0.7×	3.5k 1.8×	389	25.8k
Ching‐Hon Pui United States	110	8.6k 0.8×	10.5k 1.2×	3.2k 0.6×	2.2k 0.6×	1.5k 0.8×	629	45.5k
Luigi Terracciano Switzerland	86	8.7k 0.8×	9.2k 1.1×	3.6k 0.6×	4.4k 1.1×	4.1k 2.1×	565	26.2k
Dan L. Longo United States	84	6.4k 0.6×	7.5k 0.9×	8.8k 1.6×	1.7k 0.4×	2.4k 1.2×	365	25.3k

Countries citing papers authored by Phyllis A. Gimotty

Since Specialization

Citations

This map shows the geographic impact of Phyllis A. Gimotty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllis A. Gimotty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllis A. Gimotty more than expected).

Fields of papers citing papers by Phyllis A. Gimotty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phyllis A. Gimotty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllis A. Gimotty. The network helps show where Phyllis A. Gimotty may publish in the future.

Co-authorship network of co-authors of Phyllis A. Gimotty

This figure shows the co-authorship network connecting the top 25 collaborators of Phyllis A. Gimotty. A scholar is included among the top collaborators of Phyllis A. Gimotty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phyllis A. Gimotty. Phyllis A. Gimotty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gimotty, Phyllis A., Andrew Matthews, Ronac Mamtani, et al.. (2025). Evolving racial/ethnic disparities in AML survival in the novel therapy era. Blood Advances. 9(3). 533–544. 1 indexed citations

Crissey, Mary Ann S., Monika Bhardwaj, Vaibhav Jain, et al.. (2024). Divergent effects of acute and chronic PPT1 inhibition in melanoma. Autophagy. 21(2). 394–406. 3 indexed citations

Straker, Richard J., Phyllis A. Gimotty, Emily Y. Chu, et al.. (2022). Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB/C melanoma: A population-based analysis. Journal of the American Academy of Dermatology. 88(4). 802–807. 11 indexed citations

Afroz, Sumbul, Ceylan Tanes, Kyle Bittinger, et al.. (2022). SARS-CoV-2–specific T cells in unexposed adults display broad trafficking potential and cross-react with commensal antigens. Science Immunology. 7(76). eabn3127–eabn3127. 29 indexed citations

Haas, Naomi B., Leonard J. Appleman, Mark N. Stein, et al.. (2019). Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma. Clinical Cancer Research. 25(7). 2080–2087. 112 indexed citations

Abbott, James, Laura A. Taylor, Giorgos C. Karakousis, et al.. (2018). Histological immune response patterns in sentinel lymph nodes involved by metastatic melanoma and prognostic significance. Journal of Cutaneous Pathology. 45(6). 377–386. 6 indexed citations

Sinnamon, Andrew J., Yun Song, Madalyn G. Neuwirth, et al.. (2018). The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex. Journal of the American Academy of Dermatology. 79(2). 245–251. 21 indexed citations

Zhang, Dongmei, Gao Zhang, Zhongyi Hu, et al.. (2017). Oncogenic RAS Regulates Long Noncoding RNA Orilnc1 in Human Cancer. Cancer Research. 77(14). 3745–3757. 29 indexed citations

Facompre, Nicole D., Xavier Solé, Sheheryar Kabraji, et al.. (2016). JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers. Cancer Research. 76(18). 5538–5549. 37 indexed citations

10.

Sehgal, Alison R., Phyllis A. Gimotty, Jianhua Zhao, et al.. (2015). DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia. Clinical Cancer Research. 21(7). 1614–1620. 39 indexed citations

11.

Higuchi, Tomoe, Dallas B. Flies, Nicole A. Marjon, et al.. (2015). CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer. Cancer Immunology Research. 3(11). 1257–1268. 235 indexed citations

12.

Basu, Devraj, Arnaud F. Bewley, Steven M. Sperry, et al.. (2013). EGFR Inhibition Promotes an Aggressive Invasion Pattern Mediated by Mesenchymal-like Tumor Cells within Squamous Cell Carcinomas. Molecular Cancer Therapeutics. 12(10). 2176–2186. 18 indexed citations

13.

Ohashi, Shinya, Mitsuteru Natsuizaka, Seiji Naganuma, et al.. (2011). A NOTCH3-Mediated Squamous Cell Differentiation Program Limits Expansion of EMT-Competent Cells That Express the ZEB Transcription Factors. Cancer Research. 71(21). 6836–6847. 89 indexed citations

14.

Thompson, John F., Seng-Jaw Soong, Charles M. Balch, et al.. (2011). Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database. Journal of Clinical Oncology. 29(16). 2199–2205. 250 indexed citations

15.

Michaylira, Carmen Z., Gabrielle S. Wong, Charles G. Miller, et al.. (2010). Periostin, a Cell Adhesion Molecule, Facilitates Invasion in the Tumor Microenvironment and Annotates a Novel Tumor-Invasive Signature in Esophageal Cancer. Cancer Research. 70(13). 5281–5292. 97 indexed citations

16.

Balch, Charles M., Jeffrey E. Gershenwald, Seng-Jaw Soong, et al.. (2009). Final Version of 2009 AJCC Melanoma Staging and Classification. Journal of Clinical Oncology. 27(36). 6199–6206. 3342 indexed citations breakdown →

17.

Ma, Xinrong, Kelly J. Norsworthy, Namita Kundu, et al.. (2009). CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model. Molecular Cancer Therapeutics. 8(3). 490–498. 124 indexed citations

18.

Ziober, Amy, Kirtesh R. Patel, Faizan Alawi, et al.. (2006). Identification of a Gene Signature for Rapid Screening of Oral Squamous Cell Carcinoma. Clinical Cancer Research. 12(20). 5960–5971. 88 indexed citations

19.

Zhang, Lin, Jia Huang, Nuo Yang, et al.. (2006). Integrative Genomic Analysis of Protein Kinase C (PKC) Family Identifies PKCι as a Biomarker and Potential Oncogene in Ovarian Carcinoma. Cancer Research. 66(9). 4627–4635. 109 indexed citations

20.

Ming, Michael E., Ross M. Levy, Ole Hoffstad, et al.. (2004). Validity of Patient Self-reported History of Skin Cancer. Archives of Dermatology. 140(6). 730–5. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact